Key facts
- Melodi’s last known valuation is $31.0M.
- It has raised $15.0M; the latest was Early Stage VC ($10.8M) in Aug 2024.
- Notable investors include Engage Venture Partners, HM Venture Partners, Southeast Minnesota Capital Fund, Three Bridges Private Capital.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Melodi
- ·The full record, as it builds
Funding rounds
No funding rounds for Melodi are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Melodi
Manufacturer of medical devices intended to improve outcomes for women undergoing breast reconstruction. The company is developing a novel absorbable scaffold containing antibiotics that support soft tissue and improve patient outcomes, offered at a lower price than the current standard of care, enabling women to reduce healthcare costs for breast surgery.
- Sector
- Healthcare
- HQ
- Minneapolis, MN, United States
- Founded
- 2021
- Employees
- 7
- Website
- melodihealth.com/
- Ownership
- Privately Held (backing)
Melodi doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Melodi shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Melodi in its N-PORT filings yet. We sweep new filings monthly.